EQUILLIUM, INC. Depreciation
EQUILLIUM, INC. (EQ) reported Depreciation of $50.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-13
- EQUILLIUM, INC. depreciation for the quarter ending 2026-06-30 was $26.00K, a 18.75% decline year-over-year.
- EQUILLIUM, INC. depreciation for the quarter ending 2026-03-31 was $24.00K, a 27.27% decline year-over-year.
- EQUILLIUM, INC. depreciation for the quarter ending 2025-12-31 was $23.00K, a 34.29% decline year-over-year.
- EQUILLIUM, INC. depreciation for the quarter ending 2025-09-30 was $28.00K, a 20.00% decline year-over-year.
- EQUILLIUM, INC. depreciation for fiscal 2025 was $116.00K, a 15.33% decline from fiscal 2024.
- EQUILLIUM, INC. depreciation for fiscal 2024 was $137.00K, a 8.73% increase from fiscal 2023.
- EQUILLIUM, INC. depreciation for fiscal 2023 was $126.00K, a 6.78% increase from fiscal 2022.
- EQUILLIUM, INC. depreciation for fiscal 2022 was $118.00K, a 63.89% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 10 month | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $50.00K 10-Q · filed 2026-08-13 | $73.00K derived: sum of 3 quarters · filed 2026-08-13 | $101.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2026-03-31 | $24.00K 10-Q · filed 2026-05-13 | $47.00K derived: sum of 2 quarters · filed 2026-05-13 | $75.00K derived: sum of 3 quarters · filed 2026-05-13 | $107.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-12-31 | $23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $51.00K derived: sum of 2 quarters · filed 2026-03-25 | $83.00K derived: sum of 3 quarters · filed 2026-08-13 | $116.00K 10-K · filed 2026-03-25 | ||
| 2025-09-30 | $28.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $60.00K derived: sum of 2 quarters · filed 2026-08-13 | $93.00K 10-Q · filed 2025-11-13 | $128.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-06-30 | $32.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $65.00K 10-Q · filed 2026-08-13 | $100.00K derived: sum of 3 quarters · filed 2026-08-13 | $135.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | $33.00K 10-Q · filed 2026-05-13 | $68.00K derived: sum of 2 quarters · filed 2026-05-13 | $103.00K derived: sum of 3 quarters · filed 2026-05-13 | $138.00K derived: sum of 4 quarters · filed 2026-05-13 | ||
| 2024-12-31 | $35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $70.00K derived: sum of 2 quarters · filed 2026-03-25 | $105.00K derived: sum of 3 quarters · filed 2026-03-25 | $137.00K 10-K · filed 2026-03-25 | ||
| 2024-09-30 | $35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $70.00K derived: sum of 2 quarters · filed 2025-11-13 | $102.00K 10-Q · filed 2025-11-13 | $135.00K derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $67.00K 10-Q · filed 2025-08-14 | $100.00K derived: sum of 3 quarters · filed 2025-08-14 | $131.00K derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | $32.00K 10-Q · filed 2025-05-14 | $65.00K derived: sum of 2 quarters · filed 2025-05-14 | $96.00K derived: sum of 3 quarters · filed 2025-05-14 | $127.00K derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $64.00K derived: sum of 2 quarters · filed 2025-03-27 | $95.00K derived: sum of 3 quarters · filed 2025-03-27 | $126.00K 10-K · filed 2025-03-27 | ||
| 2023-09-30 | $31.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $62.00K derived: sum of 2 quarters · filed 2024-11-13 | $93.00K 10-Q · filed 2024-11-13 | |||
| 2023-06-30 | $31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $62.00K 10-Q · filed 2024-08-08 | ||||
| 2023-03-31 | $31.00K 10-Q · filed 2024-05-09 | |||||
| 2022-12-31 | $118.00K 10-K · filed 2024-03-25 | |||||
| 2021-12-31 | $72.00K 10-K · filed 2023-03-23 | |||||
| 2020-12-31 | $45.00K 10-K · filed 2022-03-23 | |||||
| 2019-12-31 | $23.00K 10-K · filed 2021-03-24 | |||||
| 2018-12-31 | $6.00K 10-K · filed 2020-03-26 | $6.10K 10-K · filed 2019-03-27 | ||||
| 2017-12-31 | $122.00 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |